[go: up one dir, main page]

CN102942470B - Production technology of pharmaceutical grade valeryl chloride - Google Patents

Production technology of pharmaceutical grade valeryl chloride Download PDF

Info

Publication number
CN102942470B
CN102942470B CN201210432079.6A CN201210432079A CN102942470B CN 102942470 B CN102942470 B CN 102942470B CN 201210432079 A CN201210432079 A CN 201210432079A CN 102942470 B CN102942470 B CN 102942470B
Authority
CN
China
Prior art keywords
chloride
valeric acid
thionyl chloride
stabilizer
storage tank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210432079.6A
Other languages
Chinese (zh)
Other versions
CN102942470A (en
Inventor
方永勤
褚俊轩
武安邦
许亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou University
Original Assignee
Changzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou University filed Critical Changzhou University
Priority to CN201210432079.6A priority Critical patent/CN102942470B/en
Publication of CN102942470A publication Critical patent/CN102942470A/en
Application granted granted Critical
Publication of CN102942470B publication Critical patent/CN102942470B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a production technology of pharmaceutical grade valeryl chloride, relating to the field of chemical industry production. The production technology disclosed herein comprises the following steps: respectively pumping n-valeric acid and thionyl chloride into an enamel reaction kettle from storage tanks by using a metering pump, wherein the ratio of n(n-valeric acid) to n(thionyl chloride) is 1.0:1.2-1.0:1.5; then measured as n-valeric acid, adding 1-5wt% of DMF, heating up to 50-90 DEG C to react until no gas is generated; sucking the chlorination reaction liquid into a rectifying still under vacuum condition, measured as n-valeric acid, adding 1-5wt% of stabilizer, conducting rectification under vacuum, controlling the temperature of the rectifying still being no higher than 90 DEG C, collecting the front cut fraction thionyl chloride into a receiving storage tank, and collecting valeryl chloride into a finished product storage tank. According to the invention, by adding the electron-rich stabilizer to allow acyl cations to preferentially be combined with the stabilizer, thus the generation of valeric anhydride is avoided; simultaneously the temperature of the rectifying still is reduced, the equilibrium constant of valeryl chloride dissociation is reduced, and the stability of distillation separation is raised.

Description

医药级正戊酰氯的生产工艺Production process of pharmaceutical grade n-valeryl chloride

技术领域 technical field

本发明涉及化工生产领域,具体涉及一种医药级正戊酰氯的生产工艺。 The invention relates to the field of chemical production, in particular to a production process of pharmaceutical grade n-valeryl chloride.

背景技术 Background technique

正戊酰氯是一种具有广泛用途的化工产品,如可用于合成农药杀菌剂己唑醇;向列型苯基环己烷液晶材料;降压药培哚普利、缬沙坦、厄贝沙坦;以及用于有机合成领域的基团保护等。其中医药级正戊酰氯的产品附价值高,质量指标也最为严格,要求正戊酰氯含量≥99.5%、正戊酸酐含量≤0.2%、正戊酸含量≤0.25%、无磷元素残余等。 N-valeryl chloride is a chemical product with a wide range of uses, such as the synthesis of pesticide fungicide hexaconazole; nematic phenylcyclohexane liquid crystal material; antihypertensive drugs perindopril, valsartan, irbeza Tan; and group protection in the field of organic synthesis, etc. Among them, pharmaceutical-grade n-valeryl chloride has high added value and the most stringent quality indicators, requiring n-valeryl chloride content ≥ 99.5%, n-valeric anhydride content ≤ 0.2%, n-valeric acid content ≤ 0.25%, and no phosphorus residues.

正戊酰氯的生产方法是以正戊酸为原料,经氯化试剂氯化合成,可选的氯化试剂有光气、氯化亚砜、三氯化磷、五氯化磷,草酰氯等。从原料来源及成本考虑,氯化亚砜及三氯化磷的应用最为广泛。由于医药级正戊酰氯要求无磷元素残余,而三氯化磷氯化过程中生成的磷酸与戊酰氯沸点接近,后处理困难,故氯化亚砜为氯化试剂较为合适。 The production method of n-valeryl chloride is to use n-valeric acid as the raw material and synthesize it by chlorination with chlorinating reagents. The optional chlorinating reagents include phosgene, thionyl chloride, phosphorus trichloride, phosphorus pentachloride, oxalyl chloride, etc. . Considering the sources of raw materials and cost, thionyl chloride and phosphorus trichloride are the most widely used. Since the pharmaceutical grade n-valeryl chloride requires no residual phosphorus element, and the phosphoric acid generated in the chlorination process of phosphorus trichloride has a boiling point close to that of valeryl chloride, so post-treatment is difficult, so thionyl chloride is more suitable as a chlorination reagent.

氯化生产过程中通常添加DMF为催化剂,以提高反应动力学及氯化选择性,避免生成的正戊酰氯与未反应的正戊酸缩合形成正戊酸酐。其催化机理为:DMF与氯化亚砜经缩合、重排,脱去SO2形成Vilsmeier试剂,其氯化活性比氯化亚砜更强,使得羧酸优先与其发生氯化反应,机理如下所示。 In the chlorination production process, DMF is usually added as a catalyst to improve the reaction kinetics and chlorination selectivity, and avoid the condensation of n-valeryl chloride and unreacted n-valeric acid to form n-valeric anhydride. The catalytic mechanism is as follows: DMF and thionyl chloride undergo condensation and rearrangement to remove SO 2 to form Vilsmeier reagent. Its chlorination activity is stronger than that of thionyl chloride, so that carboxylic acid is preferentially chlorinated with it. The mechanism is as follows Show.

然而,该体系精馏收集的126-127℃馏分,纯度≥98%(GC),其中正戊酸酐含量在1%左右,仅满足农药级产品指标,且精馏釜底残余5~10%黑色焦油。 However, the 126-127°C fraction collected by rectification in this system has a purity of ≥98% (GC), and the content of n-valeric anhydride is about 1%, which only meets the pesticide-grade product index, and 5-10% of the black residue at the bottom of the rectification tank tar.

发明内容 Contents of the invention

针对上述生产存在问题,本发明的目的在于提供一种高含量医药级正戊酰氯的生产工艺,本发明可通过以下技术方案实施: For above-mentioned production existence problem, the object of the present invention is to provide a kind of production technique of high-content pharmaceutical grade n-valeryl chloride, the present invention can be implemented through the following technical solutions:

1. 将正戊酸、氯化亚砜分别由储罐经计量泵打入搪瓷反应釜中,n(正戊酸):n(氯化亚砜)=1.0:1.2~1.0:1.5,再以正戊酸计加入1~5wt‰DMF,升温至50~90℃,直至反应至无气体放出; 1. Put n-valeric acid and thionyl chloride into the enamel reaction kettle through the metering pump respectively from the storage tank, n(n-valeric acid):n(thionyl chloride)=1.0:1.2~1.0:1.5, and then Add 1~5wt‰DMF to the meter of n-valeric acid, raise the temperature to 50~90℃, until no gas is released during the reaction;

2. 将上述氯化反应液真空吸入精馏釜中,以正戊酸计加入1~5wt‰稳定剂,减压精馏,控制精馏釜温≤90℃,前馏分氯化亚砜收集至接收储罐,正戊酰氯收集至成品储罐。 2. Vacuum suck the above-mentioned chlorination reaction solution into the rectification kettle, add 1~5wt‰ stabilizer in terms of n-valeric acid, rectify under reduced pressure, control the temperature of the rectification kettle to ≤90°C, and collect the front fraction of thionyl chloride to Receiving storage tank, n-valeryl chloride is collected to the finished product storage tank.

其中步骤(2)所述的稳定剂结构见下式: Wherein the stabilizer structure described in step (2) sees the following formula:

    其中R1、R2、R3均为富电子取代基,例如,苯基,烷基或烷氧基中的一种或几种。 Wherein R 1 , R 2 and R 3 are all electron-rich substituents, for example, one or more of phenyl, alkyl or alkoxy.

本发明的有益效果Beneficial effects of the present invention

    一般精馏工序后期即使保持较高的回流比等,出料馏分中正戊酸酐含量逐步升高。由此可见,戊酰氯(125~127℃)与戊酸酐(228~230℃)沸点虽然相差较大,但存在共沸现象。其中正戊酸酐的可能生成机理如下所示。 Generally, even if a high reflux ratio is maintained in the later stage of the rectification process, the content of n-valeric anhydride in the output fraction will gradually increase. It can be seen that although the boiling points of valeryl chloride (125~127°C) and valeric anhydride (228~230°C) are quite different, there is an azeotropic phenomenon. The possible formation mechanism of n-valeric anhydride is shown below.

正戊酰氯受热后分子运动加剧,离解成酰基正离子与氯负离子。酰基正离子亲电进攻正戊酰氯的烯醇式互变异构体,形成酯类化合物,释放一分子氯化氢。该酯类化合物再次受到酰基正离子的亲电进攻,形成正戊酸酐和氯代烯烃。该机理符合生产过程中有氯化氢气体溢出及黑色焦油生成的现象。 The molecular motion of n-valeryl chloride intensifies after being heated, and dissociates into acyl cations and chloride anions. The acyl cation electrophilically attacks the enol tautomer of n-pentanoyl chloride to form an ester compound, releasing a molecule of hydrogen chloride. The ester compound is subjected to the electrophilic attack of the acyl cation again to form n-valeric anhydride and chlorinated alkenes. This mechanism is consistent with the phenomenon that hydrogen chloride gas overflows and black tar is generated during the production process.

本发明通过添加富电子结构的稳定剂,使得酰基正离子优先与稳定剂结合,避免正戊酸酐的生成。同时降低精馏釜温度,降低正戊酰氯离解的平衡常数,提高精馏分离的稳定性。 In the present invention, by adding a stabilizer with an electron-rich structure, the acyl positive ion is preferentially combined with the stabilizer to avoid the generation of n-valeric anhydride. At the same time, the temperature of the rectification kettle is lowered, the equilibrium constant of n-valeryl chloride dissociation is lowered, and the stability of rectification separation is improved.

具体实施例 specific embodiment

实施例1Example 1

将100kg正戊酸、140kg氯化亚砜分别由储罐,经计量泵打入500L搪瓷反应釜中,再加入0.1kg DMF,打开蒸汽阀门,升温至50℃,生成的酸性气体由尾气吸收装置进行吸收,反应直至无气体放出。将上述反应液真空吸入200L精馏釜中,加入0.1kg N,N-二甲基苯胺,减压精馏,控制釜温≤90℃,回收氯化亚砜23kg,收集正戊酰氯115kg,纯度99.7%(GC),收率98%。 Put 100kg of n-valeric acid and 140kg of thionyl chloride into the 500L enamel reaction kettle through the metering pump respectively from the storage tank, then add 0.1kg of DMF, open the steam valve, and raise the temperature to 50°C, the generated acid gas is discharged from the tail gas absorption device Absorb and react until no gas is released. Vacuum suck the above reaction solution into a 200L rectification kettle, add 0.1kg of N,N-dimethylaniline, rectify under reduced pressure, control the temperature of the kettle to ≤90°C, recover 23kg of thionyl chloride, and collect 115kg of n-pentanoyl chloride. 99.7% (GC), yield 98%.

实施例2Example 2

将100kg正戊酸、175kg氯化亚砜分别由储罐,经计量泵打入500L搪瓷反应釜中,再加入0.2kg DMF,打开蒸汽阀门,升温至70℃,生成的酸性气体去尾气吸收装置进行吸收,反应直至无气体放出。将上述反应液真空吸入200L精馏釜中,加入0.5kg 三苯胺,减压精馏,控制釜温≤90℃,回收氯化亚砜57kg,收集正戊酰氯113kg,纯度99.6%(GC),收率96%。 Put 100kg of n-valeric acid and 175kg of thionyl chloride into the 500L enamel reaction kettle through the metering pump respectively from the storage tank, then add 0.2kg of DMF, open the steam valve, raise the temperature to 70°C, and remove the generated acid gas to the tail gas absorption device Absorb and react until no gas is released. Vacuum suck the above reaction liquid into a 200L rectification kettle, add 0.5kg of triphenylamine, rectify under reduced pressure, control the temperature of the kettle to ≤90°C, recover 57kg of thionyl chloride, and collect 113kg of n-valeryl chloride with a purity of 99.6% (GC). The yield is 96%.

实施例3Example 3

将100kg正戊酸、152kg氯化亚砜分别由储罐,经计量泵打入500L搪瓷反应釜中,再加入0.5kg DMF,打开蒸汽阀门,升温至90℃,生成的酸性气体去尾气吸收装置进行吸收,反应直至无气体放出。将上述反应液真空吸入200L精馏釜中,加入0.3kg 三乙醇胺,减压精馏,控制釜温≤90℃,回收氯化亚砜35kg,收集正戊酰氯114kg,纯度99.7%(GC),收率97%。 Put 100kg of n-valeric acid and 152kg of thionyl chloride into the 500L enamel reaction kettle through the metering pump respectively from the storage tank, then add 0.5kg of DMF, open the steam valve, raise the temperature to 90°C, and remove the generated acid gas to the tail gas absorption device Absorb and react until no gas is released. Vacuum suck the above reaction solution into a 200L rectification kettle, add 0.3kg of triethanolamine, rectify under reduced pressure, control the temperature of the kettle to ≤90°C, recover 35kg of thionyl chloride, and collect 114kg of n-valeryl chloride with a purity of 99.7% (GC). The yield is 97%.

Claims (1)

1.医药级正戊酰氯的生产工艺,其特征在于按照下述步骤进行: (1)将正戊酸、氯化亚砜分别由储罐经计量泵打入搪瓷反应釜中,n(正戊酸):n(氯化亚砜)=1.0:1.2~1.0:1.5,再以正戊酸计加入质量计1~5w‰的DMF,升温至50~90℃,直至反应至无气体放出; 1. The production process of pharmaceutical-grade n-valeryl chloride is characterized in that it is carried out in accordance with the following steps: (1) n-valeric acid and thionyl chloride are respectively injected into the enamel reaction kettle through a metering pump from a storage tank, and n (n-pentyl chloride) acid): n (thionyl chloride)=1.0:1.2~1.0:1.5, then add DMF with a mass of 1~5w‰ in terms of n-valeric acid, heat up to 50~90°C, until no gas is released during the reaction; (2)将上述氯化反应液真空吸入精馏釜中,以正戊酸计加入质量计1~5‰稳定剂,减压精馏,控制精馏釜温≤90℃,前馏分氯化亚砜收集至接收储罐,正戊酰氯收集至成品储罐; (2) Vacuum suck the above-mentioned chlorination reaction solution into the rectification kettle, add 1~5‰ stabilizer in terms of mass based on n-valeric acid, rectify under reduced pressure, control the temperature of the rectification kettle to ≤90°C, and the front fraction chlorinated chlorinated The sulfone is collected into the receiving storage tank, and the n-valeryl chloride is collected into the finished product storage tank; 其中步骤(2)所述的稳定剂结构见下式: Wherein the stabilizer structure described in step (2) sees the following formula:     其中R1、R2、R3为苯基,烷基或烷氧基中的一种或几种。  where R1, R2, R3 are one or more of phenyl, alkyl or alkoxy.
CN201210432079.6A 2012-11-02 2012-11-02 Production technology of pharmaceutical grade valeryl chloride Expired - Fee Related CN102942470B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210432079.6A CN102942470B (en) 2012-11-02 2012-11-02 Production technology of pharmaceutical grade valeryl chloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210432079.6A CN102942470B (en) 2012-11-02 2012-11-02 Production technology of pharmaceutical grade valeryl chloride

Publications (2)

Publication Number Publication Date
CN102942470A CN102942470A (en) 2013-02-27
CN102942470B true CN102942470B (en) 2015-06-24

Family

ID=47725491

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210432079.6A Expired - Fee Related CN102942470B (en) 2012-11-02 2012-11-02 Production technology of pharmaceutical grade valeryl chloride

Country Status (1)

Country Link
CN (1) CN102942470B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880646A (en) * 2014-03-13 2014-06-25 东力(南通)化工有限公司 Hydrolysis-resistant rectifying process of isovaleryl chloride
CN115477578B (en) * 2022-10-18 2024-04-26 中国人民解放军61699部队 Purification method of nonanoyl chloride

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1373742A (en) * 1999-09-13 2002-10-09 巴斯福股份公司 Method for producing acid chlorides
CN101007774A (en) * 2007-01-29 2007-08-01 浙江大学 Method for synthesizing D-norvaline using n-pentanoic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5172820B2 (en) * 2007-03-01 2013-03-27 三井化学株式会社 Method for producing carboxylic acid chloride

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1373742A (en) * 1999-09-13 2002-10-09 巴斯福股份公司 Method for producing acid chlorides
CN101007774A (en) * 2007-01-29 2007-08-01 浙江大学 Method for synthesizing D-norvaline using n-pentanoic acid

Also Published As

Publication number Publication date
CN102942470A (en) 2013-02-27

Similar Documents

Publication Publication Date Title
KR20100134755A (en) Method for preparing bis (fluorosulfonyl) imide anion compound and ion counter compound
CN108047031A (en) The preparation method of 2,4,6- tri-methyl chlorides and its application for being used to prepare phosphorous photoinitiator
CN102942470B (en) Production technology of pharmaceutical grade valeryl chloride
CN105271246A (en) Method for preparing chlorinated disilane by utilization of polysilicon byproducts
CN103012275A (en) Method for producing high-purity N-alkyl imidazole
CN102993226B (en) Prepare the method for phenyldimethylchlorosilane
CN102942593B (en) Synthetic method of photoinitiator dual (2,4,6-trimethylbenzene formyl group) phenyl phosphine oxide
CN102898307B (en) Synthetic method of methyl 4-chlorobutyrate
CN107759445A (en) One kind prepares 1(3,3, Dimethylcyclohexyl)The method of ethanol
CN102020610A (en) Low-viscosity ionic liquid
CN105503822A (en) Preparation method for trifluoromethyl benzothiophene derivative and purification method for product of preparation method
CN103420844B (en) Preparation of 4,4'-diaminodiphenylmethane by condensation of aniline and formaldehyde catalyzed by acidic ionic liquid
CN105085158A (en) Synthesis method of methyl benzotrifluoride
CN107602489B (en) A method of bis- substitution -1,2,3- triazole of 1,4- is prepared with green solvent
CN105330545A (en) Method for recycling oxalic acid from triazine ring cyclization mother liquor dreg with tin chloride as catalyst
CN101580473B (en) Method for preparing N-methyl paranitroaniline
WO2016043079A1 (en) Method for producing 2'-trifluoromethyl group-substituted aromatic ketone
WO2011015101A1 (en) Process for separating 5-hydroxy-4-methyl-2-5[h]-furanone
CN103467268B (en) Preparation method of 2,2'- dyhydroxyl-4,4'-dimethoxybenzophenone
CN104529726B (en) A kind of preparation method of o-hydroxyacetophenone
CN102372677A (en) Method and equipment for rapidly manufacturing ionic liquid by promoting synthesis reaction by microwaves
CN103787847B (en) A kind of take ionic liquid as the technique of solvent continuous production trimethyl orthoacetate
CN108047114B (en) Halogenated trifluoromethylpyrrole derivatives and preparation method and application thereof
CN113717026B (en) Method for rapidly synthesizing n-bromobutane
JP6074670B2 (en) Process for producing arene compounds containing perfluoroalkenyloxy groups

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150624

Termination date: 20211102